Global Mass Spectrometry Market 2018-2022
About Mass Spectrometry
Mass spectrometry (MS) is an analytical instrument that ionizes chemical species and sorts ions based on their mass-to-charge ratio. It is used in many different fields such as the pharmaceutical and chemical industries to analyze pure samples as well as complex mixtures.
Technavio’s analysts forecast the global mass spectrometry market to grow at a CAGR of 6.83% during the period 2018-2022.
Covered in this report
The report covers the present scenario and the growth prospects of the global mass spectrometry market for 2018-2022. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
Technavio Announces the Publication of its Research Report – Global Mass Spectrometry Market 2018-2022
Technavio recognizes the following companies as the key players in the global mass spectrometry market: Agilent Technologies, Bruker, Danaher, PerkinElmer, Shimadzu Corporation, and Thermo Fisher Scientific.
Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is increasing demand for mass spectrometers in personalized medicine. Personalized medicine is the tailoring of medical treatment to the individual characteristics of each patient. Personalized medicine, a multi-faceted approach to patient care, improves the ability to diagnose and treat diseases and also offers the potential to detect a disease at an earlier stage when it is easier to treat effectively.”
According to the report, one driver in the market is rising focus on drug discovery and development. There is an increased focus on drug discovery and development by pharmaceutical and biotechnology companies as well as research institutes due to the rise in the prevalence of several chronic diseases globally. For instance, four major chronic diseases prevalent globally are CVDs, cancer, chronic obstructive pulmonary disease, and type 2 diabetes, which occur due to high blood pressure, high blood cholesterol, obesity, lack of physical activity, unhealthy diet, and tobacco use.
Further, the report states that one challenge in the market is high cost of instrument. Mass spectrometers with specific and advanced features are expensive and accrue high maintenance cost due to which their adoption can be hindered. In cases of customization as per end-user needs, the total cost of the mass spectrometer can increase. On average, the price of a mass spectrometer ranges between $1,000-$100,000.
Thermo Fisher Scientific
Other prominent vendors